Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Marker Therapeutics Inc
MRKRCurrent price
1.25 USD
-0.01 USD (-0.79%)
Last closed
1.30 USD
Company
www.markertherapeutics.com
ISIN
US57055L1070
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
36 854 016 USD
Yield for 12 month
-74.17 %
1Y
3Y
5Y
10Y
15Y
MRKR
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of novel T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. Its multi tumor associated antigen-specific T cell technology is based on the manufacture of non-engineered tumor-specific T cells that recognize multiple tumor-associated antigens. The company also develops MT-401-OTS for the treatment of acute myeloid leukemia; and MT-601 to treat lymphoma and pancreatic cancer. Marker Therapeutics, Inc. is headquartered in Houston, Texas. Address: 9350 Kirby Drive, Houston, TX, United States, 77054
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
19.00 USDP/E ratio
–Dividend Yield
–Current Year
+3 311 133 USD
Last Year
+9 004 530 USD
Current Quarter
+1 926 020 USD
Last Quarter
+1 169 236 USD
Current Year
-7 105 656 USD
Last Year
+5 324 081 USD
Current Quarter
+1 926 020 USD
Last Quarter
+1 169 236 USD
Key Figures MRKR
1 year
3 years
5 years
10 years
EBITDA
-11 792 272 USD
Operating Margin TTM
Price to Earnings
–
Return On Assets TTM
-40.87 %
PEG Ratio
–
Return On Equity TTM
-71.74 %
Wall Street Target Price
19.00 USD
Revenue TTM
3 727 435 USD
Book Value
1.58 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
53.30 %
Dividend Yield
–
Gross Profit TTM
-17 125 779 USD
Earnings per share
-1.07 USD
Diluted Eps TTM
-1.07 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-278.22 %
Dividend Analytics MRKR
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History MRKR
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
–
Dividend CAGR 3Y
–
Dividend CAGR 5Y
–
Dividend CAGR 10Y
–
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
–
Forward Annual Dividend
– USD
Last Split Factor
1:10
Payout Ratio
–
Last Split Date
27.01.2023
Stock Valuation MRKR
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
3.41
Price Sales TTM
9.89
Enterprise Value EBITDA
-0.22
Price Book MRQ
4.88
Financials MRKR
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators MRKR
For 52 weeks
2.44 USD
6.16 USD
50 Day MA
3.56 USD
Shares Short Prior Month
56 987
200 Day MA
3.96 USD
Short Ratio
1.55
Shares Short
50 092
Short Percent
1.09 %
BeatStart